Update on the role of the robotic assisted surgery in the treatment of pancreatic neuroendocrine tumors in the context of MEN1

#3297

Introduction: Pancreatic surgery is technically demanding and robotic assisted surgery providing improved dexterity enables the adoption of minimally invasive pancreatic surgery. Pancreatic neuroendocrine tumors (pNETs) are rare with an incidence of one per 100,000 population, accounting for 1%-4% of all pancreatic tumors. Minimally invasive surgery has an established role in the treatment of patients with pNETs. PNETs are the second most common manifestation in patients with MEN1. The most common type of pNETs in MEN1 is a non-functional tumor.

Aim(s): This systematic review aimed to investigate the role of robotic assisted surgery in the treatment of MEN1 patients with pNETs.

Materials and methods: Electronic databases were searched with the appropriate search terms up to and including November 2020. Full publications providing evidence on the effectiveness and safety of robotic assisted surgery in MEN1 patients presenting with pNETs met inclusion criteria.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Yiannakopoulou E,

Keywords: robotic assisted surgery, pNETs, MEN1,